Clarus Therapeutics Announces Closing of Upsized $30.0 Million Underwritten Public Offering Apr 27, 2022 01:43PM
Clarus Therapeutics (CRXT) Prices 26.68M Unit Offering at $1.10/unit Apr 25, 2022 09:21AM
Clarus Therapeutics Announces Pricing of Upsized $30.0 Million Underwritten Public Offering Apr 25, 2022 09:20AM
Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies Sep 9, 2021 12:46PM